Australia markets closed

Amneal Pharmaceuticals Inc (2DT.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
6.200.00 (0.00%)
As of 08:06AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,495,258
2,393,607
2,212,304
2,093,669
1,992,523
-
Cost of revenue
1,614,819
1,573,042
1,427,596
1,324,696
1,364,130
-
Gross profit
880,439
820,565
784,708
768,973
628,393
-
Operating expenses
Research development
167,726
167,778
200,046
209,563
190,585
-
Selling general and administrative
440,174
429,675
399,700
365,504
326,727
-
Total operating expenses
609,108
596,315
595,786
575,067
517,312
-
Operating income or loss
271,331
224,250
188,922
193,906
111,081
-
Interest expense
227,017
210,629
158,377
136,325
145,998
-
Total other income/expenses net
-109,875
-13,086
-278,381
-26,215
-863
-
Income before tax
-106,366
-40,270
-248,127
31,366
-35,780
-
Income tax expense
13,940
8,452
6,662
11,196
-104,358
-
Income from continuing operations
-120,306
-48,722
-254,789
20,170
68,578
-
Net income
-168,693
-83,993
-129,986
10,624
91,059
-
Net income available to common shareholders
-168,693
-83,993
-129,986
10,624
91,059
-
Basic EPS
0.07
-
-0.86
0.07
0.62
-2.74
Diluted EPS
0.06
-
-0.86
0.07
0.61
-2.74
Basic average shares
152,893
-
150,944
148,922
147,443
132,106
Diluted average shares
155,083
-
150,944
151,821
148,913
132,106